The market’s most investable theme today is not simply artificial intelligence, healthcare or macroeconomics in isolation. It is possibly the increasingly visible convergence of all three: businesses finding ways to monetize AI, healthcare platforms turning operational discipline into financial leverage, and policymakers…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
Heartflow, Inc. (NASDAQ: HTFL) is delivering the kind of growth story investors usually hope to find before it becomes obvious: rapid revenue expansion, rising gross margins, stronger adoption of a second product line, and a materially higher full-year outlook. In a market…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
Amwell’s setup going into Q2 2026 looks like the kind of telehealth story Wall Street loves to rediscover right after it has ignored it for too long. The company’s August 4 aftermarket earnings report and 5 p.m. ET webcast arrive with a…
The market’s message today is blunt but not tragic: growth cooled, inflation stayed sticky, and the megacap earnings parade is doing its best impression of a relay race with trillion-dollar batons. For investors, that usually means more dispersion, more headlines, and more…
A Tale of Three Signals
Wall Street is serving up a tidy little lesson in 2026: healthcare tech is still waiting for its encore, industrial plumbing is printing record numbers, and prestige beauty is increasingly a game of science, shelves, and selective…
Amwell’s (AMWL) leadership page reads like a small thesis on where digital care is trying to go: a mix of clinicians, operators, and technologists built to make virtual healthcare feel less like a workaround and more like a workflow. That matters because…
Amwell, Inc. (NYSE: AMWL, $13,02, +165.07% YTD)) is quietly scripting one of Wall Street’s more intriguing digital‑health turnarounds—an AI‑infused, platform‑first story backed by a management bench that looks more like a health‑tech all‑star team than a typical telehealth cast.
Digital Care, Rewritten…
Butterfly Network’s (BFLY) Midjourney cameo now sits inside a bigger, more nuanced script: AI‑driven imaging that can delight investors, unnerve ethicists, and occasionally confuse radiologists—all while telehealth platforms like Amwell (AMWL) quietly wire the whole thing into everyday care. The result is…
